MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.33−0.01 (-0.75%)
Close on Nov 18, 2026Market cap $65.46MP/E –Yield –
MediciNova revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
MediciNova's revenue for the twelve months ending Jun 30, 2026 was $920.48K. For fiscal 2025 it was $409.66K, down 59.0% from the year before. The highest annual figure on record is $4.04M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $409.66K | -59.0% |
| FY2023 | Dec 31, 2023 | $1.00M | -75.2% |
| FY2021 | Dec 31, 2021 | $4.04M | +123863.8% |
| FY2013 | Dec 31, 2013 | $3.26K | -99.6% |
| FY2012 | Dec 31, 2012 | $802.58K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $458.44K | +240.6% |
| Q1 FY2026 | Mar 31, 2026 | $186.98K | – |
| Q4 FY2025 | Dec 31, 2025 | $151.74K | -84.8% |
| Q3 FY2025 | Sep 30, 2025 | $123.32K | – |
| Q2 FY2025 | Jun 30, 2025 | $134.60K | +258.9% |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $1.00M | -75.0% |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $37.50K | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $4.00M | – |
See a number that looks wrong?